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Abstract Human p100 protein was ¢rst identi¢ed as a tran-
scriptional coactivator of Epstein^Barr virus nuclear antigen 2,
and has been shown to be a coactivator of other cellular trans-
activators. Its roles in development of vertebrate embryos, how-
ever, have not been reported. We have identi¢ed a zebra¢sh
ortholog of the human p100 coactivator. The zebra¢sh p100
transcript is processed to two alternative variants, long and
short forms, referred to as p100L and p100S, respectively.
Both GFP-p100L and GFP-p100S fusion proteins are located
in the cytoplasm of transfected culture cells and microinjected
embryonic cells. Analysis of transcripts with Northern blots
revealed the presence of p100L and lower amounts of p100S
mRNAs from the one-cell stage throughout the life cycle.
Whole-mount in situ hybridization shows that p100L and
p100S share the same spatiotemporal expression pattern. Their
zygotic expression is initially restricted to axial mesoderm pre-
cursors during gastrulation, and then spreads over other tissues
during segmentation, and ¢nally is constrained to some internal
organs at day 5. We also ¢nd that Nodal signaling is essential
for the zygotic expression of p100. These studies pave the way
to understanding in depth the role of p100 during vertebrate
embryogenesis.
0 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The human p100 protein was ¢rst identi¢ed as a coactivator
of Epstein^Barr virus nuclear antigen (EBNA) 2 [1]. EBNA-2
plays a key role in activating other viral genes when the virus
infects and immortalizes B-lymphocytes [2]. Because p100
binds TFIIE, an essential component of RNA polymerase II
initiation complexes, p100 probably acts as a bridge between
EBNA-2 and the basal transcription machinery [1]. The p100
protein has been found to interact with and enhance tran-
scriptional activity of c-Myb [3,4], a hematopoietic transcrip-
tional factor, and STAT6, a central mediator of interleukin-4-
induced gene responses [5]. As a coactivator, p100 protein is
exclusively localized in the nuclei in several types of human
cells [1]. Interestingly, Keenan et al. [6] have identi¢ed the
p100 protein as a constituent of endoplasmic reticulum and
cytosolic lipid droplets from milk-secreting cells of mouse and
cow [6]. The p100 protein is also enriched both in nuclei and
in endoplasmic reticulum/organelle fractions of mammary ep-
ithelial cells in response to prolactin in culture and in mam-
mary tissue during lactation [7]. These studies suggest that
p100 may play a role in a variety of important cellular events.
Moreover, a p100-like protein has also been identi¢ed in
plants [8], suggesting evolutionary conservation of p100.
We have identi¢ed a zebra¢sh ortholog of the human p100
gene. In zebra¢sh, the p100 gene has two alternatively spliced
transcripts, and green £uorescent protein (GFP)-p100 chimer-
ic proteins translated from both splice variants are localized in
the cytoplasm of cultured and embryonic cells. Maternal tran-
scripts of p100 are distributed in all embryonic cells before
gastrulation. Then expression becomes largely restricted to
axial mesoderm during gastrulation and early segmentation,
which is regulated by Nodal signaling.
2. Materials and methods
2.1. Embryos
Zebra¢sh (Danio rerio) of the AB strain were maintained and bred
as described by Wester¢eld [9]. Homozygous oepm134 mutant embryos
were produced by mating heterozygous mutant ¢sh. Embryos from a
cross of oepm134 were injected with 100 pg wild-type oep mRNA and
adult females homozygous for the mutant allele were identi¢ed sub-
sequently, as described by Gritsman et al. [10]. Maternal and zygotic
oep (MZoep) embryos were produced by mating homozygous oepm134
females to heterozygous oep males. All embryos were raised at 28.5‡C
in Holtfreter water (0.05 g/l KCl,0.1 g/l CaCl, 0.2 g/l NaHCO3, 3.5 g/l
NaCl).
2.2. Isolation of p100 cDNAs
The shorter transcript form of the zebra¢sh p100 gene, p100S, was
initially identi¢ed during a systematic search of a cDNA library,
which was constructed in plasmid vector pcDNA3.0, for organ- or
tissue-speci¢c genes during early embryogenesis (see [11] for details).
An expressed sequence tag (EST) clone (fm53a04) that contains the
longer transcript form of p100, p100L, was purchased from Invitro-
gen. The sequences of p100S and p100L were deposited in the Gen-
Bank database with accession numbers AF422806 and AY272050,
respectively.
2.3. Plasmid constructs
For determining subcellular localization of p100, the coding se-
quence of p100S and p100L was ampli¢ed by polymerase chain reac-
tion (PCR) and placed immediately downstream of the GFP coding
sequence of vector peGFP-C2, which generated plasmids peGFP-
p100S and peGFP-p100L, respectively. A p100L-speci¢c sequence of
approximately 1.8 kb was ampli¢ed by PCR with a pair of speci¢c
primers (5P-GGGCGATCAAGAATGGCAAAGGAC-3P and 5P-CA-
AAACATAGACATCTGACTGAGC-3P) and cloned into vector pT-
Easy to generate plasmid pP100L-1.8 kb.
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2.4. Reverse transcription (RT)-PCR and Northern blot
Total RNA was isolated from embryos at di¡erent stages using
Trizol (Gibco BRL). A pair of speci¢c primers (5P-GGGCGATCAA-
GAATGGCAAAGGAC-3P and 5P-TCACAGATGGTGGTATAG-
TTGAC-3P) was used to amplify by RT-PCR a p100S-speci¢c region
of 263 bp. First-strand cDNAs synthesized from total RNA were used
as templates. PCR reactions were performed for 30 cycles (94‡C, 30 s;
58‡C, 30 s; 72‡C, 1 min) and a ¢nal extension at 72‡C for 10 min. As
an internal control, a 475 bp sequence of L-actin cDNA was ampli¢ed
by RT-PCR using two speci¢c primers (5P-ATGGATGATGAA-
ATTGCCGCAC-3P and 5P-ACCATCACCAGAGTCCATCACG-3P).
The ampli¢ed products were analyzed on agarose gels.
For Northern blots, total RNA was run on 1.2% formaldehyde-
containing gels with 20 Wg RNA per lane and then transferred onto
a nylon membrane. The insert in pP100S, the original plasmid isolated
from the library, was radiolabeled by random priming in the presence
of [K-32P]dCTP and hybridized to RNA using the ExpressHyb1 hy-
bridization kit (Clontech). A ¢nal post-hybridization wash was carried
out in 0.2USSC, 0.1% SDS at 60‡C.
2.5. RNA synthesis
Capped mRNAs for squint (sqt), lefty1 (previously named antivin)
and oep were synthesized in vitro using the T7 Cap-Scribe kit (Roche)
according to the manufacturer’s recommendation. RNA was puri¢ed
using RNAeasy0 Mini Kit (Qiagen) and diluted in nuclease-free 0.1 M
KCl to an appropriate concentration prior to microinjection.
2.6. Transfection and microinjection
Plasmids peGFP-p100S, peGFP-p100L and peGFP-C2 (control)
were ¢rst used to transfect HeLa cells using the calcium phosphate
transfection system (Life Technologies). DNA from these plasmids
was also microinjected into one-cell embryos at a dose of about 100
pg. The embryonic cells were dispersed from the injected embryos at
80% epiboly stage, and these cells as well as transfected HeLa cells
were observed for GFP by confocal microscopy. RNA was micro-
injected into the yolk of one-cell stage wild-type embryos. The micro-
injection dose was referred to the amount of DNA or RNA per
embryo.
2.7. Whole-mount in situ hybridization
To detect the expression pattern of p100, antisense RNA probes
were generated by in vitro transcription in the presence of digoxi-
genin-UTP using di¡erent templates. The plasmid pP100S linearized
with BamHI was used as a template and the probe derived was used,
unless otherwise stated, to detect both p100L and p100S transcripts.
To make p100S-speci¢c antisense probe, the template used was a 600
bp fragment recovered from a PstI digest of pP100S. This fragment
contains a 480 bp p100S-speci¢c sequence, a 100 bp sequence com-
mon in p100S and p100L, and the SP6 promoter. For detecting p100L
expression only, plasmid pP100L-1.8 kb was linearized with SacII
prior to in vitro transcription. The embryos at di¡erent stages were
¢xed in 4% paraformaldehyde. The in situ hybridization essentially
followed the protocol described by Wester¢eld [9].
3. Results
3.1. Zebra¢sh p100 produces two alternative transcripts
The p100S cDNA was initially identi¢ed by whole-mount in
situ hybridization as a tissue-speci¢c gene in zebra¢sh. This
cDNA has a full length of 2191 bp and contains an open
reading frame (ORF) between positions 107 and 1756 that
encodes a putative peptide of 549 residues. BLAST searches
revealed that the putative p100S protein shares an identity of
87.4% and 86.3% with EBNA-2 coactivator p100 of human [1]
and mouse (GenBank accession number BAA84944), respec-
tively, in the N-terminal region of 542 residues. To con¢rm
whether p100S is a zebra¢sh ortholog of the human p100, we
determined its genetic position in the genome. As shown in
Fig. 1B, p100S maps to linkage group 4 of the zebra¢sh ge-
nome, falling into a stretch of conserved synteny with human
chromosome 7 (Hsa7). This is consistent with the interpreta-
tion that p100S is an ortholog of the human p100 gene.
Because human p100 consists of 885 residues, we hypothe-
sized that p100S is a truncated form of full-length p100 of
zebra¢sh. Northern blots revealed a major transcript (p100L)
of about 3.7 kb together with a minor 2.2 kb transcript
(p100S) (Fig. 1C). We identi¢ed a zebra¢sh EST (fm53a04)
from the GenBank database, the 5P sequence of which is iden-
tical to that of p100S and the 3P sequence of which encodes an
amino acid sequence sharing high homology with the C-ter-
minal domain of human p100. Sequencing this EST revealed
that its most 5P 1710 bp sequence of the 3654 bp full-length
sequence is identical to p100S, implying that it is an alterna-
tive transcript of the p100 locus. We therefore name it p100L.
A 2667 bp ORF identi¢ed in p100L encodes a putative pep-
tide of 888 residues. The putative p100L protein is identical in
amino acid sequence to p100S in the N-terminal region of 535
residues, and shares an overall identity of 85% with human
p100.
3.2. GFP-tagged chimeric proteins of both p100L and p100S
are localized in the cytoplasm
Human p100 contains four and a half repeats of sequence
homologous to bacterial staphylococcal nuclease (SNase) and
a tudor domain [12,13]. Similarly, zebra¢sh p100L has all of
these domains (Fig. 1A). In contrast, p100S contains only the
¢rst three SNase repeats and an incomplete fourth repeat, and
lacks the tudor domain.
As a transcription coactivator, human p100 functions in the
nucleus [1,3^5]. Because the two isoforms of zebra¢sh p100
are very di¡erent in length, we wondered whether either of
them acts in the nucleus. To test this possibility, p100L and
p100S were individually fused to GFP, and the resulting fu-
sion constructs were used for transfection into cultured HeLa
cells and for microinjection into zebra¢sh embryos. As shown
in Fig. 1E, both GFP-p100L and GFP-p100S fusion proteins
became localized to the cytoplasm, rather than in the nuclei,
of the transfected human HeLa cells. To avoid misinterpreting
the results from the in vitro assay, we further analyzed the
subcellular localization of zebra¢sh p100 proteins in embry-
onic zebra¢sh cells by microinjecting DNA of the fusion con-
structs into one-cell stage embryos and observing GFP £uo-
rescence during gastrulation. The results showed that both
GFP-p100L and GFP-p100S were exclusively present in the
cytoplasm of embryonic cells. This cytoplasmic localization is
unexpected, but needs to be further tested for the endogenous
proteins.
3.3. Expression of p100 is dynamic during embryogenesis
Northern blots showed that both p100 mRNA variants are
present in embryos at all tested stages despite their dramatic
quantitative di¡erence (Fig. 1C). Because the band represent-
ing p100S is very faint, we performed RT-PCR to con¢rm the
expression of p100S. As shown in Fig. 1D, p100S transcript
was detected at all stages tested, supporting the conclusion
that p100S, like p100L, is expressed throughout the life
cycle.
To detect spatial expression of p100 in zebra¢sh embryos,
we performed whole-mount in situ hybridization. Because
p100S and p100L share the same 5P sequence of 1710 bp,
any full-length antisense probes derived from them can pro-
duce the same in situ hybridization pattern. Therefore we tried
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to identify speci¢c expression patterns using di¡erent probes
derived from transcript-speci¢c regions.
We ¢rst used a 1.8 kb p100L-speci¢c probe to investigate
the spatial and temporal expression pattern of p100L. Consis-
tent with the Northern blot result, transcripts of p100L were
¢rst detected in the single-cell embryo, indicating their mater-
nal origin. During the following blastula period, p100L tran-
scripts were evenly distributed in all blastomeres (Fig. 2A). At
the onset of gastrulation, stronger staining occurred in the
embryonic shield, while in other regions staining was weaker
(Fig. 2B). This di¡erence in the distribution of p100L tran-
scripts may re£ect its localized zygotic expression. As embryos
elongated along the anteroposterior axis by convergence, ex-
tension and involution of cells [14], the p100L staining domain
in the shield migrated toward the animal pole and formed a
longitudinal band in the dorsal midline. Accordingly, during
late gastrulation, the p100L expression domain developed into
a continuous band in the dorsal midline extending from the
tailbud to the animal pole (Fig. 2C,E). This band comprises
the prechordal plate anteriorly and the notochord posteriorly
(Fig. 2F,G). Zebra¢sh goosecoid (gsc) is expressed during gas-
trulation in the anterior of the prechordal plate from which
head mesoderm and pharyngeal endoderm derives [15]. Dou-
ble staining with p100L and gsc shows that the anteriormost
domain of p100L precedes the gsc expression domain (Fig.
2D). The anteriormost domain of p100L gives rise to the
hatching gland, as also evidenced by its subsequent move-
ment. During early segmentation, the anteriormost hatching
gland domain of p100L grew wider, while in the forming
notochord the staining intensity increased in the anterior to
posterior direction (Fig. 2H^J). Thereafter, the anterior do-
main migrated away from the forming head and by the end of
segmentation formed a ring-like band on the surface of the
yolk antero-lateral to the head region (Fig. 2K,L). At this
stage, the expression level was so low that it was almost un-
detectable in the anterior notochord but higher in the poste-
Fig. 1. Characterization of zebra¢sh p100. A: Sequence structures of putative p100L and p100S proteins. The ¢rst 535 residues are identical in
both isoforms. Numbers above the lines indicate positions of residues. SNase repeats are shown in red boxes and the tudor domain in blue. Se-
quences unique to p100L and p100S are indicated by di¡erent colors (light blue or yellow). B: Chromosomal localization of zebra¢sh p100 on
linkage group 4 showing conserved synteny with human p100 on Hsa7. C: Northern blot showing the presence of a larger, major band
(p100L) and a smaller, minor band (p100S). Molecular markers are indicated on the left. D: Ampli¢cation of a p100S-speci¢c sequence by RT-
PCR shows that it is present in all stages examined. The positive control used p100S plasmid DNA as the PCR template. The negative control
(labeled as no RT) used total RNA, rather than the ¢rst-strand cDNA, of one-cell embryos as the PCR template. Lower panel shows ampli¢-
cation of zebra¢sh L-actin. E: Subcellular localization of p100L and p100S. Constructs peGFP-C2, peGFP-100L and peGFP-100S were used to
transfect cultured human HeLa cells (top panel) or were injected into fertilized zebra¢sh eggs that were dispersed at the 80% epiboly stage (low-
er panel). The cells were observed for GFP by confocal microscopy. Both fusion proteins GFP-100L and GFP-100S are localized in the cyto-
plasm surrounding a black hole (nucleus), whereas GFP alone (peGFP-C2) is present both in the nuclei and in the cytoplasm.
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rior notochord (Fig. 2K,L). We note that p100L also began to
be expressed in paraxial mesoderm soon after the onset of
segmentation and in many more types of tissues at later
stages. For example, the transcripts were detected in the brain,
eyes and somites at 24 h (Fig. 2K,L). On day 5, p100L was
expressed in the liver, the pancreas and the intestine (Fig.
2M,N).
To look into the expression pattern of p100S, we used a 600
bp p100S-speci¢c probe, 480 bp of which is derived from the
3P-most sequence of p100S. The short length of this probe
required a much longer staining period and as a result caused
higher background. Nonetheless, this probe detected p100S
expression during gastrulation in the anterior prechordal plate
and the notochord precursors (Fig. 2O^R). On day 5, very
weak expression was also detected in the liver, the pancreas
and the intestine (data not shown). This result suggests that
the spatiotemporal expression pattern of p100S is identical to
that of p100L.
3.4. Nodal signaling is required for p100 expression
Nodal proteins, members of the transforming growth fac-
tor-L superfamily, have been found to be essential for the
development of mesoderm and endoderm in vertebrates [16].
Two zebra¢sh Nodal-related genes, i.e. cyclops (cyc) and sqt,
have been isolated. Double mutant embryos for cyc and sqt
lack a visible embryonic shield at the onset of gastrulation and
later fail to form mesendodermal tissues [17]. The expression
pattern of p100 suggested the hypothesis that p100 expression
is under the control of Nodal signals. To test this idea, we ¢rst
injected one- to four-cell stage wild-type embryos with di¡er-
ent doses of sqt mRNA and examined p100L expression with
the p100L-speci¢c antisense probe. When the injection dose
exceeded 5 pg, the expression of of p100L was signi¢cantly
enhanced well before gastrulation (Fig. 3B). Lower doses,
however, also stimulated p100L expression as seen at later
stages. For example, 39% of embryos (n=45) injected at a
dose of 0.5 pg had expanded expression domains of p100L
in the prechordal plate and the notochord at the bud stage
Fig. 2. Spatiotemporal expression of p100 detected by in situ hy-
bridization. A^N: Expression pattern of p100L. O^R: Expression
pattern of p100S. A: Animal-pole view at two-cell stage showing
transcript in both cells (labeled with black arrowheads) but not in
the yolk cell. B: Animal-pole view at 50% epiboly showing staining
in the embryonic shield. C: Dorsal view at 80% epiboly. D: Dorsal
view showing that the expression domain of p100L (blue) extends
more rostrally than that of gsc (red) at 80% epiboly. The gsc do-
main is bracketed. E: Dorsal view at the bud stage. F,G: Cross-sec-
tions of a bud-stage embryo (as in E) at the level of anterior pre-
chordal plate (F) and the middle position (G) along the
anteroposterior axis. H^J: Lateral (H), animal-pole (I) and dorsal
(J) views at ¢ve-somite stage. K: Head region of a 24-h embryo.
L: Lateral view of a 24-h embryo. M: Dorsal view at day 5 show-
ing expression in internal organs. The pancreas is located on the
right. N: Lateral view at a higher magni¢cation at day 5. O,P: Ani-
mal-pole (O) and dorsal views (P) at the bud stage. Q,R: Animal-
pole (Q) and dorsal views (R) at 10-somite stage. Because the
p100S-speci¢c probe is short, it requires a much longer staining pe-
riod, which results in higher background. e, eyes; es, embryonic
shield; fb, ¢n buds; g, gut; hg, hatching gland; lv, liver; mb, mid-
brain; n, notochord; p, pancreas; pp, prechordal plate.
Fig. 3. p100 expression is regulated by Nodal signals. Embryos were
hybridized with antisense probe for full-length p100S, which detects
both p100L and p100S transcripts. A,B: Lateral views of uninjected
(A) and sqt-injected (B) embryos at about 40% epiboly. Animal
pole is on the top. The staining in the injected embryo is visible
while it is undetectable in the uninjected embryo. Note that the ep-
iboly is delayed in injected embryos. C,D: Dorsal views of an unin-
jected (C) and sqt-injected embryos (D) at the bud stage. Animal
pole is on the top. Note widening of the axial staining. E,F: Ani-
mal-pole views of uninjected (E) and lefty1-injected (F) embryos at
70% epiboly. Dorsal is to the right. G,H: Dorsal views of unin-
jected (G) and lefty1-injected (H) embryos at the bud stage. The an-
imal pole is on the top. Note that the axial staining is missing in
the injected embryos (F,H). I,J: Animal-pole views of wild-type (I)
and MZoep mutant (J) embryos at shield stage, showing that there
is no staining in the presumptive embryonic shield of the MZoep
embryo. K,L: Animal-pole views of wild-type (K) and MZoep mu-
tant (L) embryos at 80% epiboly. Dorsal is to the right. The axial
staining is absent in the mutant embryo. M,N: Animal-pole views
of heterozygous (M) and homozygous (N) embryos (Zoep) for
oepm134 locus at 90% epiboly. Note that in the Zoep mutant embryo
staining in the prechordal plate is reduced but the notochord stain-
ing remains unchanged. O,P: Animal-pole views of heterozygous
(O) and homozygous (P) Zoep embryos at ¢ve-somite stage. Note
that the Zoep mutant embryo has very weak staining in the hatch-
ing gland. am, axial mesoderm; es, embryonic shield; hg, hatching
gland; n, notochord; pp, prechordal plate.
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(Fig. 3D). With increasing doses of injected sqt mRNA, more
embryos failed to undergo gastrulation and had a high level of
p100L expression in all cells (data not shown). The propor-
tions of embryos that failed to gastrulate were 0%, 28.8% and
55.3% at doses of 0.5 pg, 1 pg and 5 pg, respectively. We also
found that injection of sqt mRNA similarly induced transcript
that hybridized to the p100-speci¢c probe (data not shown).
These results suggest that Nodal signal is able to induce the
expression of both p100L and p100S.
Like mouse Lefty, zebra¢sh Lefty1, previously called Anti-
vin, can act as an antagonist of Nodal. Ectopic expression of
lefty1 resulted in phenotypes identical to those in cyc ;sqt dou-
ble mutants and such e¡ects can be overridden by overexpres-
sion of cyc or sqt [18,19]. We speculated that overexpression
of lefty1 should inhibit zygotic expression of p100. Embryos
injected with 100 pg of lefty1 mRNA did not accumulate
detectable amounts of p100 transcript in the embryonic shield
at the onset of gastrulation in in situ hybridization experi-
ments using the full-length p100S antisense probe. During
gastrulation, the injected embryos did not show expression
of p100 in midline mesoderm tissues (Fig. 3E^H). This result
supports the idea that zygotic expression of p100 is under the
control of the Nodal signaling pathway.
EGF-CFC proteins, acting as coreceptors, are required for
Nodal signaling [20]. Loss of maternal and zygotic function of
the zebra¢sh EGF-CFC factor Oep (in MZoep mutant) phe-
nocopies the sqt ;cyc double mutation [10]. In MZoep mutant
embryos, p100 expression was absent in the embryonic shield
(Fig. 3J) and later in the midline mesoderm tissues (Fig. 3L).
Maternal p100 transcripts, however, were detected in these
embryos at the one-cell stage (data not shown). These ¢ndings
imply that the Nodal signal activates the zygotic transcription
of the p100 gene but is not required for its maternal expres-
sion.
To determine the role of zygotic Oep in regulating p100
expression, we decided to examine p100 expression in zygotic
oep mutant (Zoep) embryos, which show loss or reduction of
the prechordal plate and the notochord [21]. During early
gastrulation, embryos produced by a pair of oepm134 hetero-
zygous ¢sh showed no obvious di¡erence in the expression
pattern of p100 compared to wild-type embryos. By the com-
pletion of gastrulation, 23 out of 94 (24.5%) embryos, the
expected proportion for homozygous mutants (25.0%),
showed weaker staining in the hatching gland primordium,
while the expression in their notochord was not a¡ected
(Fig. 3N). At the ¢ve-somite stage, mutant embryos had a
few positive cells in the area that the hatching gland normally
occupies (Fig. 3P). These results indicate that zygotically pro-
duced Oep is required for the maintenance of p100 expression
in the prechordal plate, but not in the notochord.
4. Discussion
We have identi¢ed a zebra¢sh ortholog of mammalian p100
protein, a coactivator of EBNA-2 [1]. Expression of the zebra-
¢sh p100 gene produces two transcript isoforms, p100L and
p100S, with predominance of p100L. Like human p100, ze-
bra¢sh p100L contains four and a half repeats of SNase ho-
molog and a tudor domain. In contrast, p100S contains only
the ¢rst three SNase repeats and a partial fourth repeat. Hu-
man p100 has been found to act in the nucleus as a bridge
between transactivators and the basal transcription machinery
[1,3^5]. We ¢nd, however, that GFP-marked chimeric proteins
of both p100L and p100S are localized in the cytoplasm of
cultured cells or embryonic cells. Although many studies have
demonstrated that GFP-tagged proteins retain their normal
biological activities (for examples see [22^24]), the faithful
localization of endogenous p100L and p100S proteins requires
con¢rmation with a p100-speci¢c antibody and a role for
these proteins in the nucleus cannot be excluded at this point.
Nevertheless, cytoplasmic localization of p100 or p100-like
proteins in other species has also been observed [6^8].
The zygotic expression of zebra¢sh p100 occurs during
early gastrulation in the axial mesoderm and later on in
many more tissues, suggesting a possibility that p100 proteins
play roles in the formation and di¡erentiation of these tissues.
Because its zygotic expression is positively regulated by Nodal
signaling, it will be interesting to investigate whether and how
p100 proteins are involved in developmental processes regu-
lated by Nodal signaling. The high reproductivity and external
development of embryos have made zebra¢sh a vertebrate
species most appropriate for large-scale chemical mutagenesis
[25]. Recent advances in targeted mutagenesis in zebra¢sh
allow rapid production of mutants de¢cient for speci¢c loci
[26]. Generation of mutants with loss-of-function of p100 will
help to disclose functions of p100 in the development of ver-
tebrate embryos.
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